Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia and the T315I mutation.
LAMPGEN ANALYSIS
Why it matters
The same-day regular approval addressed a mutation-defined chronic-phase population.
What research teams should watch
Capture the T315I result and confirm the indication-specific dosing in the historical label.
PRIMARY RECORDS